Repaglinide (Sandoz Inc)
Welcome to the PulseAid listing for the Repaglinide drug offered from Sandoz Inc. This Glinide [EPC],Potassium Channel Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sandoz Inc |
| NON-PROPRIETARY NAME: | Repaglinide |
| SUBSTANCE NAME: | REPAGLINIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Glinide [EPC],Potassium Channel Antagonists [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2013-12-27 |
| END MARKETING DATE: | 0000-00-00 |
Repaglinide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Repaglinide from Sandoz Inc |
| LABELER NAME: | Sandoz Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.5(mg/1) |
| START MARKETING DATE: | 2013-12-27 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0781-5148_2a5d1f34-37aa-49d2-8f28-73acc5589df9 |
| PRODUCT NDC: | 0781-5148 |
| APPLICATION NUMBER: | ANDA078555 |
Other REPAGLINIDE Pharmaceutical Manufacturers / Labelers:
